PLSE Pulse Biosciences, Inc.
$54.66 +3.79%
Updated
Healthcare · Surgical & Medical Instruments & Apparatus
Pulse Biosciences, Inc. (PLSE) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $3.9 billion. Shares last traded at $54.66, near their 52-week high. Over the past year the stock is up 263.9%.
Market Cap
$3.9B
Shares Out
71.3M
EPS (TTM)
$-5.57
P/E Ratio
—
P/S Ratio
3290.17
P/B Ratio
39.18
Dividend / Share
—
Dividend Yield
—
52-Week High
$55.25
52-Week Low
$12.59
Volume
31,635
Avg Vol (3m)
21,893.238
Performance
1W
+12.48%
1M
+44.27%
3M
+103.03%
6M
+194.29%
YTD
+309.48%
1Y
+263.95%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
77.88
SMA (50)
$37.44
SMA (200)
$23.89
Price vs SMA50
+46.02%
Price vs SMA200
+128.83%
ATR (14)
$2.62
Financials
Revenue
$1M
Net Income
$-80M
Gross Margin
0.3%
Operating Margin
—
Net Margin
—
Return on Equity
-80.5%
Return on Assets
-69.3%
Current Ratio
9.63
Debt / Equity
0.16
Revenue Growth (YoY)
—
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2022 | $-1.50 | 2022-11-10 |
| Q2 2022 | $-1.02 | 2022-08-10 |
| Q3 2022 | $-1.76 | 2022-11-10 |
| Q2 2022 | $-1.29 | 2022-08-10 |
Surgical & Medical Instruments & Apparatus peers
PLSE vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated
P/S vs peers
3290.17 / 2.94 med
+111957% premium
1–14 of 14
| SYK | Stryker Corporation | $118.2B | 31.69 | 4.57 | 14.4% | -1.31% |
| MMM | 3M | $86.8B | 28.97 | 3.45 | 11.9% | -0.28% |
| BSX | Boston Scientific | $68.0B | 18.54 | 3.24 | 17.5% | -3.17% |
| BDX | Becton Dickinson | $51.1B | 54.30 | 2.45 | 4.5% | +0.00% |
| DXCM | DexCom | $33.9B | 33.86 | 6.81 | 20.1% | +0.02% |
| RMD | ResMed | $33.1B | 21.70 | 5.85 | 26.9% | -0.78% |
| MDLN | Medline Inc. | $30.7B | — | 1.08 | — | +0.88% |
| WST | West Pharmaceutical Services | $24.1B | 42.67 | 7.25 | 17.0% | +0.00% |
| SOLV | Solventum | $15.7B | 10.97 | 1.89 | 17.3% | +0.56% |
| BAX | Baxter International | $13.2B | -12.44 | 1.15 | -9.3% | -0.51% |
| PEN | Penumbra Inc | $12.7B | 78.81 | 9.02 | 11.4% | -0.46% |
| GKOS | Glaukos Corp | $10.6B | -56.59 | 17.36 | -30.7% | +0.52% |
| GMED | Globus Medical Inc | $10.5B | 19.59 | 3.34 | 17.0% | -3.14% |
| PODD | Insulet Corporation | $10.4B | 27.82 | 3.42 | 12.3% | +1.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.